Medical experts have attributed a recent decline in breast cancer rates among U.S. women to a slide in the popularity of hormone replacement therapy. But not so fast, says one researcher. The 7% drop in rates between 2002 and 2003 appears to be due to less use of hormone therapy and at least one other, unknown factor, said Bryan Sprague of the University of Wisconsin.
Office of Strategic Communication